tiprankstipranks
Advertisement
Advertisement

HK:6622 Stock Latest News

Zhaoke Ophthalmology’s Myopia Drug NVK002 Accepted for Australian TGA Evaluation
Company AnnouncementsZhaoke Ophthalmology’s Myopia Drug NVK002 Accepted for Australian TGA Evaluation
4d ago
6622
Zhaoke Ophthalmology Launches HK$100 Million Share Buy-Back Plan
PremiumCompany Announcements
Zhaoke Ophthalmology Launches HK$100 Million Share Buy-Back Plan
11d ago
6622
Zhaoke Ophthalmology Strikes Indonesia Distribution Deal for Dry Eye Gel
PremiumCompany Announcements
Zhaoke Ophthalmology Strikes Indonesia Distribution Deal for Dry Eye Gel
14d ago
6622
Zhaoke Ophthalmology Shareholders Approve All Resolutions at 2026 AGM
PremiumCompany Announcements
Zhaoke Ophthalmology Shareholders Approve All Resolutions at 2026 AGM
1M ago
6622
Zhaoke Ophthalmology Renews Related-Party CMO Deal for Eyprotor
PremiumCompany Announcements
Zhaoke Ophthalmology Renews Related-Party CMO Deal for Eyprotor
2M ago
6622
Zhaoke Ophthalmology Sets 2026 AGM to Seek Share Repurchase and Issuance Mandates
PremiumCompany AnnouncementsZhaoke Ophthalmology Sets 2026 AGM to Seek Share Repurchase and Issuance Mandates
2M ago
6622
Zhaoke Ophthalmology Moves to Update Articles for Hybrid Meetings and New HK Rules
Premium
Company Announcements
Zhaoke Ophthalmology Moves to Update Articles for Hybrid Meetings and New HK Rules
2M ago
6622
Zhaoke Ophthalmology Narrows Core Loss as Revenue Halves in 2025
Premium
Company Announcements
Zhaoke Ophthalmology Narrows Core Loss as Revenue Halves in 2025
3M ago
6622
Zhaoke Ophthalmology Schedules Board Meeting to Approve 2025 Annual Results
PremiumCompany Announcements
Zhaoke Ophthalmology Schedules Board Meeting to Approve 2025 Annual Results
3M ago
6622
Zhaoke Ophthalmology Set to Accelerate Asia-Pacific Launch After Partner’s FDA Approval for Presbyopia Drug
PremiumCompany Announcements
Zhaoke Ophthalmology Set to Accelerate Asia-Pacific Launch After Partner’s FDA Approval for Presbyopia Drug
5M ago
6622
Zhaoke Ophthalmology Expands BRIMOCHOL™ PF Presbyopia Push to Singapore and Vietnam
PremiumCompany Announcements
Zhaoke Ophthalmology Expands BRIMOCHOL™ PF Presbyopia Push to Singapore and Vietnam
5M ago
6622
Zhaoke Ophthalmology’s Pediatric Myopia Drug Accepted for Evaluation by Australia’s TGA
PremiumCompany Announcements
Zhaoke Ophthalmology’s Pediatric Myopia Drug Accepted for Evaluation by Australia’s TGA
5M ago
6622
Zhaoke Ophthalmology Partners with TSH Biopharm for Taiwan Market Entry
PremiumCompany AnnouncementsZhaoke Ophthalmology Partners with TSH Biopharm for Taiwan Market Entry
6M ago
6622
Zhaoke Ophthalmology Gains Key Approvals for Innovative Eye Treatments
Premium
Company Announcements
Zhaoke Ophthalmology Gains Key Approvals for Innovative Eye Treatments
7M ago
6622
Zhaoke Ophthalmology Expands into Indonesia with New Distribution Agreement
Premium
Company Announcements
Zhaoke Ophthalmology Expands into Indonesia with New Distribution Agreement
8M ago
6622
Zhaoke Ophthalmology Grants 8 Million Share Options to Boost Talent Retention
PremiumCompany Announcements
Zhaoke Ophthalmology Grants 8 Million Share Options to Boost Talent Retention
9M ago
6622
Zhaoke Ophthalmology Reports Significant Revenue Decline and Increased Losses in H1 2025
PremiumCompany Announcements
Zhaoke Ophthalmology Reports Significant Revenue Decline and Increased Losses in H1 2025
10M ago
6622
Zhaoke Ophthalmology Ltd. Schedules Board Meeting for Interim Results
PremiumCompany Announcements
Zhaoke Ophthalmology Ltd. Schedules Board Meeting for Interim Results
10M ago
6622
Zhaoke Ophthalmology Secures Certification for Innovative Glaucoma Device
PremiumCompany Announcements
Zhaoke Ophthalmology Secures Certification for Innovative Glaucoma Device
11M ago
6622
Zhaoke Ophthalmology Secures FDA Orphan Drug Designation for Pediatric Eye Cancer Treatment
PremiumCompany AnnouncementsZhaoke Ophthalmology Secures FDA Orphan Drug Designation for Pediatric Eye Cancer Treatment
11M ago
6622
Zhaoke Ophthalmology’s NVK002 Gains NMPA Acceptance for Myopia Treatment
Premium
Company Announcements
Zhaoke Ophthalmology’s NVK002 Gains NMPA Acceptance for Myopia Treatment
12M ago
6622
Zhaoke Ophthalmology Updates Nomination Committee in Governance Code Compliance
Premium
Company Announcements
Zhaoke Ophthalmology Updates Nomination Committee in Governance Code Compliance
12M ago
6622

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >